INVO Fertility Q2 revenue rises, partly on acquisitions

INVO Fertility

17/08/2026 13:40

Overview
US fertility clinic operator's Q2 revenue rose 17% yr/yr, driven by acquisitions and organic growth
Net income turned positive, aided by a gain on Birmingham clinic remeasurement
Adjusted EBITDA remained negative at -$1.0 mln, reflecting ongoing platform investments

Outlook
Company plans to drive organic growth across its existing clinic network
INVO Fertility continues to evaluate acquisition opportunities for established, profitable fertility clinics
Company investing in operations, HR, and finance to support expansion and improve scalability

Result Drivers
FAMILY BEGINNINGS ACQUISITION - Q2 revenue growth was primarily attributed to the addition of Family Beginnings following its February 2026 acquisition
ORGANIC CLINIC GROWTH - Continued growth initiatives at Wisconsin Fertility Institute and the Georgia clinic contributed to first-half revenue
BIRMINGHAM CLINIC OWNERSHIP - Gain on remeasurement and future economics resulted from acquiring full ownership of the Birmingham clinic

Company press release: ID:nGNX37HlZY

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$2.18 mln
 
Q2 Net Income
 
$888,740
 
Q2 Adjusted EBITDA
 
-$1.03 mln
 

Reuters Recommended Reads
Aug 14 - Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
Aug 14 - Healthy Extracts Q2 net revenue rises 113% on acquisitions
Aug 14 - Medical device maker Retractable Technologies' Q2 sales drop on weak EasyPoint needle orders

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)